In vitro Assays and Imaging Methods for Drug Discovery for Cardiac Fibrosis

Area of Science:

• Cardiovascular Research
• Drug Discovery
• Biomedical Engineering

Background:

• Cardiac fibrosis involves excessive extracellular matrix deposition, leading to heart dysfunction and failure.
• Current treatments for cardiac fibrosis are limited due to poor understanding and inadequate predictive models.
• Developing effective antifibrotic therapies requires better in vitro models for drug screening.

Purpose of the Study:

• To review available in vitro assays for cardiac fibrosis.
• To highlight the potential of advanced 3D and coculture models.
• To discuss high-content imaging and AI for analyzing cardiac fibrosis in vitro.

Main Methods:

• Review of existing in vitro assays for cardiac fibrosis.
• Exploration of 3D cardiac organoids and coculture systems.
• Application of high-content imaging (HCI) and machine learning (ML)-based image analysis.

Main Results:

• 3D organoids and coculture systems offer more physiological models for cardiac fibrosis.
• HCI and AI-based analysis can capture the complexity of cardiac fibrosis in vitro.
• These advanced methods are nearing readiness for preclinical drug discovery.

Conclusions:

• More relevant in vitro models (3D, coculture) combined with advanced analysis (HCI, AI) are crucial.
• This combination is expected to improve the translation of findings from in vitro to in vivo studies.
• The approach will accelerate the discovery of novel targets and drugs for cardiac fibrosis.